8-K

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   ----------

                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

         Date of report (Date of earliest event reported) June 14, 2004

                          Varian Medical Systems, Inc.
             ------------------------------------------------------
             (Exact Name of Registrant as Specified in its Charter)

          Delaware                       1-7598                  94-2359345
- --------------------------------------------------------------------------------
(State or Other Jurisdiction        (Commission File           (IRS Employer
      of Incorporation)                 Number)              Identification No.)

3100 Hansen Way, Palo Alto, CA                                   94304-1030
- --------------------------------------------------------------------------------
(Address of Principal Executive Offices)                         (Zip Code)

       Registrant's telephone number, including area code (650) 493-4000

                                 Not Applicable
          -------------------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)




Item 5. Other Events and Regulation FD Disclosure.

On June 14, 2004, Varian Medical Systems, Inc. issued a press release regarding
Varian Medical Systems Announces 2-For-1 Stock Split. A copy of the press
release is attached as Exhibit 99.1 and incorporated herein by reference.

Item 7. Financial Statements and Exhibits.

      (c)   Exhibits.

            99.1 Press Release dated June 14, 2004 regarding Varian Medical
Systems Announces 2-For-1 Stock Split.


                                       2


                                   SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                         Varian Medical Systems, Inc.

                                         By: /s/ JOSEPH B. PHAIR
                                         ---------------------------------------
                                         Name: Joseph B. Phair
                                         Title: Vice President, Administration,
                                                  General Counsel and Secretary

Dated: June 14, 2004


                                       3


                                  EXHIBIT INDEX

Number                              Exhibit
- ------                              -------

 99.1       Press Release dated June 14, 2004 regarding Varian Medical Systems
            Announces 2-For-1 Stock Split.

EX-99.1

                                                                    Exhibit 99.1

              Varian Medical Systems Announces 2-for-1 Stock Split

    PALO ALTO, Calif., June 14 /PRNewswire-FirstCall/ -- Varian Medical
Systems, Inc. (NYSE: VAR) today announced that its board of directors has
declared a 2-for-1 stock split in the form of a 100 percent stock dividend on
the company's outstanding common stock.  Holders of the company's common stock
will receive one additional share of common stock for every share of common
stock they own.
    The dividend will be paid on July 30, 2004, to stockholders of record on
June 30, 2004.  After the stock dividend, Varian Medical Systems will have
approximately 136.2 million shares of stock outstanding.  The board declared
the stock dividend on Friday, June 11, following a special meeting of the
company's stockholders who voted to increase the number of authorized shares
of common stock by 90 million shares to a total of 189 million shares.
    "This stock dividend reflects management confidence in the continued
growth prospects of our company," said Richard M. Levy, chairman and CEO of
Varian Medical Systems.  "We expect it will enhance market interest in Varian
Medical Systems and increase the liquidity of the stock."
    Varian Medical Systems' board also amended its November 12, 2003,
authorization to repurchase 3 million shares to reflect the effect of the
stock dividend on shares that remain available for purchase at the payable
date.  Before adjusting for this stock dividend, the company now has
approximately 2 million shares remaining on the current repurchase
authorization that extends through August 31, 2005.

    Varian Medical Systems, Inc., of Palo Alto, California is the world's
leading manufacturer of integrated cancer therapy systems, which are treating
thousands of patients per day.  The company is also a premier supplier of
X-ray tubes and flat-panel digital subsystems for imaging in medical,
scientific, and industrial applications.  Varian Medical Systems employs
approximately 3,160 people who are located at manufacturing sites in North
America and Europe and in its 56 sales and support offices around the world.
In its most recent fiscal year ended September 26, 2003, Varian Medical
Systems reported sales of over $1 billion.  Additional information is
available on the company's web site at www.varian.com.

    Forward Looking Statements
    Statements in this press release regarding future business, events, plans,
objectives, expectations, estimates, and other similar matters, including
statements using the term "expect," constitute forward-looking statements
within the meaning of the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995.  Such forward-looking statements contained in
this press release are subject to risks and uncertainties that could cause
actual results to differ materially from those anticipated, including, but not
limited to, certain risks beyond the control of the Company and other risks as
described in the Company's Annual Report on Form 10-K and other reports filed
from time to time by the Company with the Securities and Exchange Commission.
These forward-looking statements represent the Company's judgment as of the
date of this press release.  The Company discloses no interest or obligation
to update these forward-looking statements.

    CONTACT:  Elisha Finney, +1-650-424-6803, or elisha.finney@varian.com, or
Spencer Sias, +1-650-424-5782, or spencer.sias@varian.com, both of Varian.

SOURCE  Varian Medical Systems, Inc.
    -0-                             06/14/2004
    /CONTACT:  Elisha Finney, +1-650-424-6803, or elisha.finney@varian.com, or
Spencer Sias, +1-650-424-5782, or spencer.sias@varian.com, both of Varian/
    /Web site:  http://www.varian.com /
    (VAR)

CO:  Varian Medical Systems, Inc.
ST:  California
IN:  BIO MTC HEA
SU:  STS